DK1267899T3 - ssa-inaktiverede salmonellavacciner - Google Patents

ssa-inaktiverede salmonellavacciner

Info

Publication number
DK1267899T3
DK1267899T3 DK01930419T DK01930419T DK1267899T3 DK 1267899 T3 DK1267899 T3 DK 1267899T3 DK 01930419 T DK01930419 T DK 01930419T DK 01930419 T DK01930419 T DK 01930419T DK 1267899 T3 DK1267899 T3 DK 1267899T3
Authority
DK
Denmark
Prior art keywords
ssa
inactivated salmonella
salmonella vaccines
vaccines
inactivated
Prior art date
Application number
DK01930419T
Other languages
Danish (da)
English (en)
Inventor
David E Lowery
Michael J Kennedy
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1267899T3 publication Critical patent/DK1267899T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01930419T 2000-03-17 2001-03-13 ssa-inaktiverede salmonellavacciner DK1267899T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19017800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
DK1267899T3 true DK1267899T3 (da) 2005-12-12

Family

ID=22700305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01930419T DK1267899T3 (da) 2000-03-17 2001-03-13 ssa-inaktiverede salmonellavacciner

Country Status (17)

Country Link
US (2) US6923957B2 (fr)
EP (1) EP1267899B1 (fr)
JP (1) JP2003527433A (fr)
AR (1) AR027680A1 (fr)
AT (1) ATE300949T1 (fr)
AU (2) AU5695701A (fr)
BR (1) BR0109322A (fr)
CA (1) CA2402252A1 (fr)
DE (1) DE60112413T2 (fr)
DK (1) DK1267899T3 (fr)
ES (1) ES2244617T3 (fr)
MX (1) MXPA02008748A (fr)
NZ (1) NZ521425A (fr)
PE (1) PE20011180A1 (fr)
PT (1) PT1267899E (fr)
WO (1) WO2001070247A2 (fr)
ZA (1) ZA200207002B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5695701A (en) * 2000-03-17 2001-10-03 Upjohn Co Salmonella vaccine materials and methods
US8337861B2 (en) * 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
CN1297315C (zh) * 2004-11-25 2007-01-31 上海交通大学 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法
ATE545701T1 (de) * 2005-05-17 2012-03-15 Ozgene Pty Ltd Sequentielles klonierungssystem
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
PT2066339E (pt) 2006-09-18 2014-10-31 Texas A & M Univ Sys Composições e métodos de potenciar respostas imunes
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
JP2011502165A (ja) * 2007-10-30 2011-01-20 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー 鞭毛細菌に対する免疫応答を強化する組成物および方法
DK2214701T3 (en) 2007-11-01 2016-12-12 Univ Arkansas CONFIGURATIONS AND METHODS FOR IMPROVING THE IMMUNE RESPONSES TO Eimeria
EP2217716A4 (fr) 2007-11-09 2011-02-09 Salk Inst For Biological Studi Utilisation d'inhibiteurs de récepteurs tam en tant qu'antimicrobiens
US8956618B2 (en) 2010-01-21 2015-02-17 The Texas A&M University System Vaccine vectors and methods of enhancing immune responses
NZ604412A (en) 2010-06-09 2015-01-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
WO2012123269A1 (fr) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Compositions immunigènes et procédés pour leur utilisation
US8481052B2 (en) 2011-05-17 2013-07-09 Cj Cheiljedang Corporation Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
WO2014066341A1 (fr) * 2012-10-22 2014-05-01 The Board Of Regents For Oklahoma State University Utilisation de protéines de sécrétion de type iii de l'espèce salmonella comme vaccination protectrice
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
CA2906079C (fr) 2013-03-15 2022-08-23 The Board Of Trustees Of The University Of Arkansas Compositions et procedes pour ameliorer les reactions immunitaires aux pathogenes enteriques
CA2967590A1 (fr) * 2014-11-11 2016-05-19 Ohio State Innovation Foundation Bacterie probiotique pour la prevention et le traitement de la salmonelle
AU2016323106A1 (en) * 2015-09-16 2018-03-29 Boehringer Ingelheim Animal Health USA Inc. Salmonella Choleraesuis-Salmonella Typhimurium vaccines
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
KR20060099543A (ko) 1994-12-09 2006-09-19 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
PT1108034E (pt) * 1998-09-04 2008-11-14 Emergent Product Dev Uk Ltd Mutantes de spi2 de salmonela atenuados como transportadores de antigénios
NZ519477A (en) * 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
AU5695701A (en) * 2000-03-17 2001-10-03 Upjohn Co Salmonella vaccine materials and methods

Also Published As

Publication number Publication date
DE60112413T2 (de) 2006-06-01
EP1267899A2 (fr) 2003-01-02
BR0109322A (pt) 2002-12-10
AU5695701A (en) 2001-10-03
AU2001256957B2 (en) 2005-08-25
JP2003527433A (ja) 2003-09-16
US20050260223A1 (en) 2005-11-24
MXPA02008748A (es) 2003-02-24
NZ521425A (en) 2004-05-28
US20040009191A1 (en) 2004-01-15
CA2402252A1 (fr) 2001-09-27
ZA200207002B (en) 2004-03-31
DE60112413D1 (de) 2005-09-08
PT1267899E (pt) 2005-11-30
US6923957B2 (en) 2005-08-02
WO2001070247A2 (fr) 2001-09-27
AR027680A1 (es) 2003-04-09
ES2244617T3 (es) 2005-12-16
ATE300949T1 (de) 2005-08-15
PE20011180A1 (es) 2001-11-15
EP1267899B1 (fr) 2005-08-03
WO2001070247A3 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
PL363005A1 (pl) Szczepionki
NO20031483D0 (no) Vaksine
NO20031705D0 (no) Vaksiner
NO20024172D0 (no) Vaksine
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
NO20026175L (no) Vaksinesammensetning
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
ATA2932001A (de) Schneefräse
DK1427444T3 (da) West-nil-vaccine
EP1284104A4 (fr) Pasteurisateur
EE05197B1 (et) Linesoliid - kristallivorm II
DK1265633T3 (da) Vaccineadjuvans
NO20033882D0 (no) Vaksine
ATE262530T1 (de) Indolochinazolinone
HUP0302612A3 (en) Salmonella vaccine
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
NO20024322D0 (no) Sekvens
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
FI20002454A0 (fi) Lämmönsiirrin
AR027982A1 (es) Aril- y heteroarilsulfonatos
ATE284887T1 (de) Thienopyrrolidinone
ATA7092001A (de) Skibindungseinstellgerät
FI20002648A0 (fi) Lämmönsiirrin